Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0000950170-25-113129

President & CEO sold 1,500 shares at $30.16 ($45,240)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-09-02 Sale : show line 1 in the form 10b5-1 −1,500 $30.16 $45,240 67,840 D
Open-market sales · 1,500 sh · avg $30.16 · $45,240
Loading xslF345X05/ownership.xml…